Liposomes
are considered as advanced drug delivery systems for
cancer treatment. A generation of pH-sensitive liposomes is being
developed that use fatty acids (FAs) as a trigger for drug release
in tumor tissues. However, FAs are also known to enhance permeability,
and it is unclear whether FAs in liposomes may cause drug leakage
or premature drug release. The passive permeability of the drug through
the membrane of the liposome is thus a crucial factor for timely drug
delivery. To investigate how the curvature and lipid composition of
liposomes affect their passive permeability, coarse-grained molecular
dynamics were performed. The permeability was determined with a counting
method. Flat bilayers and three liposomes with varying diameters were
studied, which had varying lipid compositions of dipalmitoylphosphatidylcholine,
cholesterol, and deprotonated or neutral saturated FAs. The investigated
permeants were water and two other small permeants, which have different
free energy profiles (solubility) across the membrane. First, for
the curvature effect, our results showed that curvature increases
the water permeability by reducing the membrane thickness. The permeability
increase for water is about a factor of 1.7 for the most curved membranes.
However, a high curvature decreases permeability for permeants with
free energy profiles that are a mix of wells and barriers in the headgroup
region of the membrane. Importantly, the type of experimental setup
is expected to play a dominant role in the permeability value, i.e.,
whether permeants are escaping or entering the liposomes. Second,
for the composition effect, FAs decrease both the area per lipid (APL)
and the membrane thickness, resulting in permeability increases of
up to 55%. Cholesterol has a similar effect on the APL but has the
opposite impact on membrane thickness and permeability. Therefore,
FAs and cholesterol have opposing effects on permeability, with cholesterol’s
effect being slightly stronger in our simulated bilayers. As all permeability
values were well within a factor of 2, and with liposomes usually
being larger and less curved in experimental applications, it can
be concluded that the passive drug release from a pH-sensitive liposome
does not seem to be significantly affected by the presence of FAs.